Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial

Clinical trial NCT05514912 · WITHDRAWN

Trial details

NCT number: NCT05514912
Sponsor: Emory University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Resectable Intrahepatic Cholangiocarcinoma Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8 Stage I Intrahepatic Cholangiocarcinoma AJCC v8 Stage II Intrahepatic Cholangiocarcinoma AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8

Start date: 2024-03-01
Primary completion: 2027-06-23
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.